The PI3K/AKT-signaling pathway is one of the most frequently activated signaltransduction pathways in cancer. We examined how dysregulated gene expression is associated with miRNA expression in this pathway in colorectal cancer (CRC). We used data from 217 CRC cases to evaluate differential pathway gene expression between paired carcinoma and normal mucosa and identify miRNAs that are associated with these genes. Gene expression data from RNA-Seq and miRNA expression data from Agilent Human miRNA Microarray V19.0 were analyzed. We focused on genes most associated with CRC (fold change (FC) of >1.5 or <0.67) that were statistically significant after adjustment for multiple comparisons. Of the 304 genes evaluated, 76 had a FC of <0.67, and 57 had a FC of >1.50; 47 of these genes were associated with miRNA differential expression. There were 145 mRNA:miRNA seed-region matches of which 26 were inversely associated suggesting a greater likelihood of a direct association. Most miRNA:mRNA associations were with factors that stimulated the pathway. For instance, both IL6R and PDGFRA had inverse seed-region matches with seven miRNAs, suggesting that these miRNAs have a direct effect on these genes and may be key elements in activation of the pathway. Other miRNA:mRNA associations with similar impact on the pathway were miR-203a with ITGA4, miR-6071 with ITGAV, and miR-375 with THBS2, all genes involved in extracellular matrix function that activate PI3Ks. Gene expression in the PI3K/Akt-signaling pathway is dysregulated in CRC. MiRNAs were associated with many of these dysregulated genes either directly or in an indirect manner.
| RNA processing
Formalin-fixed paraffin embedded tissue from the initial biopsy or surgery was used to extract RNA. RNA was extracted, isolated, and purified from carcinoma tissue and adjacent normal mucosa as previously described. 18 We observed no differences in RNA quality based on age of the tissue. The same RNA preparation was used to generate both the mRNA and miRNA data.
| mRNA: RNA-Seq sequencing library preparation and data processing
Total RNA from 245 colorectal carcinoma and normal mucosa pairs was chosen for sequencing based on availability of RNA and high quality miRNA data; 217 pairs passed quality control (QC) and were used in these analyses. RNA library construction was done with the Illumina TruSeq Stranded Total RNA Sample Preparation Kit with RiboZero. The samples were then fragmented and primed for cDNA synthesis, adapters were then ligated onto the cDNA, and the resulting samples were then amplified using PCR; the amplified library was then purified using Agencount AMPure XP beads. A more detailed description of the methods can be found in our previous work. 19 Illumina TruSeq v3 single read flow cell and a 50 cycle single-read sequence run was performed on an Illumina HiSeq instrument. Reads were aligned to a sequence database containing the human genome (build GRCh37/hg19, February 2009 from genome.ucsc.edu) and alignment was performed using novoalign v2.08.01. Total gene counts were calculated for each exon and UTR of the genes using a list of gene coordinates obtained from http://genome.ucsc.edu. We disregarded genes that were not expressed in our RNA-Seq data or for which the expression was missing for the majority of samples. 19 
| miRNA
The Agilent Human miRNA Microarray V19.0 was used. Data were required to pass stringent QC parameters established by Agilent that included tests for excessive background fluorescence, excessive variation among probe sequence replicates on the array, and measures of the total gene signal on the array to assess low signal. Samples failing to meet quality standards were re-labeled, hybridized to arrays, and rescanned. If a sample failed QC assessment a second time, the sample was excluded from analysis. The repeatability associated with this microarray was extremely high (r = 0.98) 17 ; comparison of miRNA expression levels obtained from the Agilent microarray to those obtained from qPCR had an agreement of 100% in terms of directionality of findings and the FCs were almost identical. 20 To normalize differences in miRNA expression that could be attributed to the array, amount of RNA, location on array, or factors that could erroneously influence miRNA expression levels, total gene signal was normalized by multiplying each sample by a scaling factor which was the median of the 75th percentiles of all the samples divided by the individual 75th percentile of each sample. 21 
| PI3K/Akt-signaling genes
The Kyoto Encyclopedia of Genes and Genomes (KEGG) (www.
genome.jp/kegg-bin/show_pathway?hsa04151) pathway map for PI3K-AKT-signaling was used to identify genes associated with this pathway. Using this map, we identified 342 genes, 304 of which had sufficient expression in CRC tissue for inclusion in the study (Supplemental Table S1 ).
| Statistical methods
We utilized a negative binomial mixed effects model in SAS (accounting for carcinoma/normal status as well as for subject effect)
to determine genes in the PI3K/Akt-signaling pathway that had a significant difference in expression between individually paired colorectal carcinoma and normal mucosa (ie, differentially expressed)
and their related fold changes (FC) . In this test we offset the overall exposure as the log expression of all identified protein-coding genes (n = 17,461). The Benjamini and Hochberg 22 procedure was used to control the false discovery rate (FDR) using a value of 0.05 or less. A FC greater than one indicates a positive differential expression (ie, upregulated in carcinoma), while a FC between zero and one indicates a negative differential expression (ie, down-regulated in carcinoma). We calculated level of expression of each gene by dividing the total expression for that gene in an individual by the total expression of all protein-coding genes per million transcripts (RPMPCG or reads per million protein-coding genes). We focused on those genes with FC of >1.50 or <0.67 for analysis with differential miRNA expression as these levels of FC may have a greater biological significance than smaller FCs.
There were 814 miRNAs expressed in greater than 20% of normal colorectal mucosa that were analyzed; differential expression was calculated using subject-level paired data as the expression in the carcinoma tissue minus the expression in the normal mucosa. In these analyses, we fit a least squares linear regression model to the RPMPCG differential expression levels and miRNA differential expression levels.
P-values were generated using the bootstrap method by creating a distribution of 10 000 F statistics derived by resampling the residuals from the null hypothesis model of no association between gene expression and miRNA expression using the boot package in R. Linear models were adjusted for age and sex. Multiplicity adjustments for gene/miRNA associations were made at the gene level using the FDR by Benjamini and Hochberg. 22 
| Bioinformatics analysis
We analyzed miRNAs and targeted mRNAs for seed region matches.
The mRNA 3′ UTR FASTA as well as the seed region sequence of the associated miRNA were analyzed to determine seed region pairings between miRNA and mRNA. MiRNA seed regions were calculated as described in our previous work 23 ; we calculated and included seeds of six, seven, and eight nucleotides in length. A seed match between the miRNA and the mRNA would increase the likelihood that identified genes associated with a specific miRNA were more likely to have a direct association, especially if there was an inverse association, given a higher propensity for binding and thus mRNA degradation. As miRTarBase 24 uses findings from many different investigations spanning across years and alignments, we used FASTA sequences generated from both GRCh37 and GRCh38 Homo sapiens alignments, using UCSC Table Browser (https://genome.ucsc.edu/cgi-bin/ hgTables). 25 We downloaded FASTA sequences that matched our
Ensembl IDs and had a consensus coding sequences (CCDS) available.
Analysis was done using scripts in R 3.2.3 and in perl 5.018002.
| RESULTS
Of the 217 study participants, 169 had been diagnosed with colon cancer, 118 were male, and 161 were non-Hispanic white ( Table 1 ).
The mean age of the study population was 64.8 years. The majority of study participants (55.6%) were diagnosed at either AJCC Stage 1 or 2.
TP53 mutations were the most common tumor molecular phenotype of cases (47.5%) and BRAF-mutated tumors were the least common tumor molecular phenotype observed (10.1%).
Of the 304 genes evaluated, 254 (83.6%) were statistically significantly dysregulated after adjustment for multiple comparisons.
Of the 254 significantly dysregulated genes, 76 had a FC of <0.67, and 57 had a FC of >1.50 (Table 2 ) (Supplemental Table S2 (Continues) Table 4 shows associations between mRNA and miRNAs without seedregion match, suggesting an indirect association between the miRNA and the mRNA, in that while miRNA and mRNA are associated, it is through the binding with other mRNA that influence the signaling pathway. In total there were 165 associations without seed-region matches. Like those miRNA and mRNA with seed-region matches, differential expression of most genes were associated with multiple miRNAs and miRNAs were associated with multiple genes. Several of the miRNAs that had seed-region matches to the mRNA, such as let-7i-5p, were also associated with other genes, but without seedregion matches. A summary of the miRNA and gene expression associations by seed-region match can be seen in Table 5 . Most miRNAs have both direct associations, supported by seed-region matches, and indirect associations with pathway genes.
| DISCUSSION
The PI3K/Akt-signaling pathway is frequently activated in cancer. Of the 304 genes evaluated 133 (43.8%) had FC differences that were <0.67 or >1.50, which is slightly higher than the rate of dysregulated genes for all protein-coding genes (37.5%). Forty-seven of the 133 dysregulated genes were associated with miRNA expression. For those mRNA and miRNAs with a seed region match, 26 were inversely associated suggesting a greater likelihood of a direct association.
Several genes within this signaling pathway have become therapeutic targets, thus a better understanding of the PI3K/Akt-signaling pathway can provide insight into the underlying biology associated with these targets.
During cellular stress, as in oncogenesis, the PI3K/Akt-signaling pathway is a key regulator of cell survival. 26 PI3K can be divided into two major subclasses that have been associated with cancer. Several miRNAs have previously been associated with genes in the PI3K/Akt-signaling pathway. 13 In the study by Josse and colleagues, the PI3K/Akt-signaling pathway was one of the top pathways associated with dysregulated miRNA expression levels. 13 MiRNAs identified as being important to this signaling pathway were miR-143, miR-145, miR-133a, and miR-223. We only identified miR-145-5p as 33 We observed associations between miR-497 and miR-106b-5p with various genes in the pathway. Differences between our study and the literature in detection of associations result from our focusing on those genes with higher FCs. Thus we did not assess genes with lower FC, such as AKT and PTEN, with miRNAs.
We utilized seed-region matches to identify miRNAs that were more likely to have a direct effect on the mRNA, leading to mRNA degradation from the miRNA binding with the 3′UTR of the mRNA.
Those matches that were most likely to have a direct effect were the 26 matches where the expression of the miRNA was opposite that of the mRNA expression. Indirect effects are most likely operating feedback and feed-forward loops. [34] [35] [36] In feedback loops, regulators such as miRNAs and transcription factors (TFs) can have either the same effect (repression of expression) or opposite effects where the TF enhances the mRNA on each other. 35 In feed-forward loops, TF regulates the miRNA as well as a target gene (TG), which is in turn also regulated by the miRNA. In this instance, the miRNA may regulate the TG directly, through seed region binding leading to mRNA degradation or translational repression, or indirectly, through repression of the TF that is influencing transcription of the same TG.
It has been suggested that regulatory paths involving miRNAs are prevalent mechanisms of gene expression. 35 Studies have shown that genes can share a regulatory network with miR-150-5p via feed forward loops. 34 As this miRNA was only associated with mRNAs with a positive beta coefficient, even when seed-region matches were identified, it is possible that this miRNA is involved in feedforward loops in CRC. and PDGFRA were associated with seven miRNAs. Both of these genes stimulate Class IA PI3Ks that in turn alter AKT. Both of these genes were associated with multiple miRNAs in the miR-17 to miR-92 cluster, including miR-17-5p, miR-19b-3p, miR-20a-5p, miR-20b-5p, miR-29b, miR-27a-3p, and miR-23a-3p. Overexpression of miR-17-5p has been shown to inhibit proliferation and trigger apoptosis. 37 MiR-20 has previously been associated with cyclin D1 38 and has been shown to be associated with vascular endothelial growth factor, a cytokine, via activation of Akt signaling. 39 MiR-27a-3p has been shown to promote cell proliferation and invasion possibly through its association with the cytokine TRAIL (TNF-related apoptosis-inducing ligand) 40 or through its effects on insulin. 41 IL6R differential expression also was inversely associated with miR-21-5p suggesting a direct association between this mRNA and miRNA. MiR-21 has been previously linked to increased inflammation and has been shown to promote Akt signaling and exert an anti-apoptotic effect. 42 Other miRNA:miRNAs that had a greater potential for a direct effect given the inverse association between the miRNA and the mRNAs that stimulated Class IA PI3Ks
were miR-203a, miR-375 and miR-607a through their inverse association with ITGA4, ITGAV, and THBS2. These direct associations also would impact the Class IA PI3Ks that could lead to indirect effects with other miRNA:mRNA associations. MiR-203a was inversely association with both PIK3CG and GNG2 expression, again suggesting a direct association that would operate at the stimulate component of the pathway. Up-regulation of miR-203 has been shown to inhibit proliferation and metastasis in CRC. 43 These associations could serve as key targets for future research.
Several miRNAs may be important given the frequent number of associated genes both with and without seed-region matches although associations do not any miRNA:mRNAs with inverse associations.
These include miR-150-5p, miR-199a-3p, miR-199a-5p, and miR199b-5p with 11 mRNAs, miR-650 with 13 mRNAs, and miR-93-5p with 7 mRNAs. MiR-150 has been shown to impair inflammatory cytokine production 44 ; ITGA3 has previously been associated with the anti-tumor miR-199 family. Over-expression of miR-93 has been shown to promote tumorigenesis and metastasis by activating the PI3K/Akt-signaling pathway. 45 YWHAB (14-3-3 proteinβ) was associated with 19 miRNA seed-region matches, two of which had inverse associations, miR-375 and miR-6515-5p.
Although our sample size is small, it is one of the largest available containing samples with paired carcinoma and normal mucosa data.
While normal colonic mucosa may not be truly "normal," it is the closest normal mucosa that can be used for a matched-paired analysis. Normal colonic mucosa was taken from the same colonic site as the tumor to prevent differences in expression from being the result of tumor location. The same RNA prep was used to generate both miRNA and mRNA data, which could minimize differences in tissue samples that could contribute to associations. We focused only on those genes that were statistically significant and also had a FC of 1.5 or greater or 0.67 or In conclusion, we find the PI3K/Akt-signaling pathway is dysregulated in CRC and that several of the dysregulated genes are associated with miRNAs. Several of these associations involve negative beta coefficients and seed-region matches between the miRNA and mRNA, suggesting that these miRNAs directly repress gene expression, and thus alter PI3K/Akt signaling; other associations we identified may be downstream effects resulting from the pathways disruption. These results need to be confirmed in other CRC studies, including laboratory-based setting. Given the prominence of the PI3K/Akt-signaling pathway in the carcinogenic process, it is important to obtain a better understanding of the underlying genomics of this pathway in an effort to help identify and refine therapeutic agents.
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